Inventiva SA revenue breakdown overview

Inventiva SA revenue for the last year amounted to 9.20 M EUR, the most of which — 9.20 M EUR — came from its highest performing source at the moment, Oral Small Molecule Therapies, the year earlier bringing 17.48 M EUR. The greatest contribution to the revenue figure was made by China — last year it brought Inventiva SA 9.13 M EUR, and the year before that — 4.61 M EUR.